Wells Fargo & Company Acrivon Therapeutics, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	N/A	-6,949 Reduced 98.01%	141 $0
Q1 2025 May 13, 2025	BUY	N/A	157 Added 2.26%	7,090 $0
Q4 2024 Feb 12, 2025	BUY	N/A	1,511 Added 27.87%	6,933 $0
Q3 2024 Nov 13, 2024	BUY	N/A	231 Added 4.45%	5,422 $0
Q2 2024 Aug 13, 2024	BUY	N/A	892 Added 20.75%	5,191 $0

Q1 2024 May 10, 2024	BUY	N/A	1,608 Added 59.75%	4,299 $0
Q4 2023 Feb 09, 2024	BUY	N/A	530 Added 24.53%	2,691 $0
Q3 2023 Nov 13, 2023	SELL	N/A	-1,144 Reduced 34.61%	2,161 $0
Q2 2023 Aug 15, 2023	BUY	N/A	1,717 Added 108.12%	3,305 $0
Q1 2023 May 12, 2023	BUY	N/A	1,588 New	1,588 $0

18.2M

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.